Date(s) - 06/21/2018
9:00 am - 3:00 pm
Pudong Shangri-La Hotel
Since the Chinese government’s announcement of the “Healthy China 2030” program in 2016, the country has prioritized the development of the life sciences and healthcare industry, making 2017 a record year for life science investments. With over 1.4 billion citizens, a growing middle class and an aging population with numerous pressing health care issues, much of the investments are flowing into pharmaceuticals, medical devices, senior care and online healthcare services.
The GCFF Shanghai Conference 2018 will be held at the Shanghai – Pudong Shangri-La, bringing life science industry players and institutional investors from throughout China, including the neighbouring Suzhou and Hangzhou life science hubs.
China: Strong Market Growth and Demand
As China’s role in the global economy grows, so too has China’s stature in global finance. Nowhere is this more readily seen than in the life sciences sector. Fueled by rapidly growing product sales, an aging population and a rising middle class, investment into global life sciences projects have increased year over year. This growth has led to significant opportunities for global life science companies that are focused on developing new pharmaceuticals, medical devices and other products in terms of capital raising and commercialization.
Why the Global Chinese Financial Forum
- 20 years of Chinese-North American investment conference experience
- Successfully held 40+ conferences
- Spread across 11+ cities around the world
- Connecting with Thousands of qualified Chinese investors globally
Past Attending Chinese Life Science Companies and Investors